Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2026-01-18 @ 11:03 AM
Study NCT ID:
NCT00109161
Status:
COMPLETED
Last Update Posted:
2008-08-05
First Post:
2005-04-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
Sponsor:
PDL BioPharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DAC-1012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None